Malignant hyperthermia in infancy and identification of novel RYR1 mutation.

Article Details

Citation

Chamley D, Pollock NA, Stowell KM, Brown RL

Malignant hyperthermia in infancy and identification of novel RYR1 mutation.

Br J Anaesth. 2000 Apr;84(4):500-4.

PubMed ID
10823104 [ View in PubMed
]
Abstract

Malignant hyperthermia (MH) has been reported as non-existent in children less than 1 yr old, although several unconfirmed reports have been published. A case report of MH in a 6-month-old child is presented, with confirmation of MH susceptibility by in vitro contracture testing of quadriceps muscle at 13 yr old. Genetic analysis revealed a novel RYR1 mutation that substitutes arginine 2452 for tryptophan in a region of the calcium channel mutated in several other MH pedigrees.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Ryanodine receptor 1P21817Details